What People Are Saying About Us...

CSDmed in Le Figaro

Le Figaro features a profile of CSDmed and its approach to medical device development, which is based on the integration of R&D, quality, and regulatory compliance.

Published on September 23, 2026, the article “CSDmed: R&D, Quality, and Regulatory Affairs: A Meaningful Triangle in the Service of Medical Devices” traces the career of Guillaume Valenzuela, founder of CSDmed, and explores the principles that led to the company’s creation.

R&D, Quality, and Regulatory Affairs: An Integrated Approach to Medical Devices

In particular, the article highlights a core belief that guides CSDmed’s work: R&D, quality, and regulatory affairs should not be treated as three separate areas.

In the development of a medical device, technical choices, risk management, regulatory requirements, verification and validation activities, and the quality management system are closely interlinked.

This approach leads CSDmed to work with both startups—helping them structure their development, QMS, and regulatory strategy from the outset—and established manufacturers seeking to ensure the soundness of their technical documentation and practices.

Regulations That Shape the Project

The profile also highlights how CSDmed approaches medical device regulation: not as a documentary exercise carried out at the end of development, but as a framework to be integrated early enough to guide decisions, strengthen risk management, and ensure the project’s success.

A philosophy summarized in the article by this sentence:

“Performance is built on attention to detail, consistency, and the ability to maintain high standards right up to the very end.”

Read the full article in Le Figaro →

Learn more